Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies - Nester, C; Appel, GB; Bomback, AS (Am J Nephrol, 2022)
et al.